|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
| Address1 | 25 MASSACHUSETTS AVENUE, NW |
Address2 | SUITE 600 |
| City | WASHINGTON |
State | DC |
Zip Code | 20001-7400 |
Country | USA |
3. Principal place of business (if different than line 2)
| City | Chicago |
State | IL |
Zip Code | 60611-5885 |
Country | USA |
|
5. Senate ID# 2877-12
|
||||||||
|
6. House ID# 304640000
|
||||||||
| TYPE OF REPORT | 8. Year | 2015 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
| 10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
| INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 12. Lobbying | 13. Organizations | ||||||||
| INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
| Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
|
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
|||||||||
| Signature | Digitally Signed By: George E. Cox III, JD |
Date | 10/20/2015 12:00:08 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code EDU
16. Specific lobbying issues
H.R. 1117, Creating Access to Residency Education Act of 2015, all provisions
S. 1148, Resident Physician Shortage Reduction Act of 2015, all provisions
Higher Education Act Reauthorization
Medical Education
Graduate Medical Education
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Aiken |
Hackett |
|
|
|
Jason |
Marino |
|
|
|
Thomas |
Roberge |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
H.R. 1725, National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015 (NASPER 2015), all provisions
H.R. 270, Flexibility in Health IT Reporting (Flex-IT) Act of 2015, all provisions
H.R. 3309, Further Flexibility in HIT Reporting and Advancing Interoperability Act (Flex-IT 2 Act), all provisions
H.R. 3100, Medical Practice Freedom Act of 2015, all provisions
H.R. 6, 21st Century Cures Act, all provisions
H.R. 293, To amend title XI of the Social Security Act to exempt from manufacturer transparency reporting certain transfers used for educational purposes, and for other purposes, all provisions
H.R. 1936, Improving the Integrity of Disability Evidence Act, all provisions
H.R. 1270, Restoring Access to Medication Act of 2015, all provisions
Affordable Care Act implementation
Precision Medicine
Diabetes Prevention
Meaningful Use burdens/penalties/interoperability
Meaningful Use Stage 3
EHR Interoperability & Certification
Telemedicine
Laboratory Developed Tests oversight and regulation
Mental Health
Opioid Abuse
Medication Assisted Therapy
ICD-10
Off-label medications for children
Electronic prescription of controlled substances
Nomination of Dr. Karen DeSalvo to be ASH, HHS
Interstate Medical Licensure Compact/Telemedicine
Physician-owned Hospitals
Health Savings Accounts - Prescription requirements for OTC medication
Drug Compounding
Antibiotic Resistance
Dietary Guidelines
Sunshine Act
FDA Regulation of Powdered Caffeine
FDA/NIH Modernization
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Health & Human Services - Dept of (HHS), Office of Management & Budget (OMB), President of the U.S., Drug Enforcement Administration (DEA), White House Office, Office of Natl Drug Control Policy (NDCP), Food & Drug Administration (FDA), Agriculture - Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Government Accountability Office (GAO)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Lindsey |
Brill |
|
|
|
Aiken |
Hackett |
|
|
|
Dana |
Lichtenberg |
|
|
|
Jason |
Marino |
|
|
|
Thomas |
Roberge |
|
|
|
Andrew |
Wankum |
|
|
|
Margaret |
Garikes |
|
|
|
Shannon |
Curtis |
|
|
|
Sandy |
Marks |
|
|
|
Sharon |
McIlrath |
|
|
|
Matthew |
Reid |
|
|
|
Koryn |
Rubin |
|
|
|
Mari |
Savickis |
|
|
|
Jason |
Scull |
|
|
|
George |
Cox |
III |
|
|
Eileen |
Carlson |
|
|
|
Debra |
Cohn |
|
|
|
Kristen |
O'Brien |
|
|
|
Sylvia |
Trujillo |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code LBR
16. Specific lobbying issues
S. 1189, Conrad State 30 and Physician Access Act, all provisions
Antitrust
Competition in the Healthcare Marketplace
Health Insurance Industry Consolidation
Narrow networks
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Federal Trade Commission (FTC)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Lindsey |
Brill |
|
|
|
Jason |
Marino |
|
|
|
Thomas |
Roberge |
|
|
|
Margaret |
Garikes |
|
|
|
Shannon |
Curtis |
|
|
|
George |
Cox |
III |
|
|
Charles |
Kels |
|
|
|
Kristen |
O'Brien |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
H.R. 1021, Protecting the Integrity of Medicare Act of 2015, all provisions
H.R. 1190, Protecting Seniors' Access to Medicare Act of 2015, all provisions
S. 141, Protecting Seniors' Access to Medicare Act of 2015, all provisions
S. 843, Improving Access to Medicare Coverage Act of 2015, all provisions
H.R. 2102, Medicare Diabetes Prevention Act of 2015, all provisions
S. 1131, Medicare Diabetes Prevention Act of 2015, all provisions
H.R. 976, Patient Access to Higher Quality Health Care Act of 2015, all provisions
H.R. 2513, Promoting Access, Competition, and Equity Act of 2015 (PACE Act), all provisions
S. 488, A bill to amend title XVIII of the Social Security Act to allow physician assistants, nurse practitioners, and clinical nurse specialists to supervise cardiac, intensive cardiac, and pulmonary rehabilitation programs, all provisions
H.R. 1936, Improving the Integrity of Disability Evidence Act, all provisions
H.R. 2519, Audiology Patient Choice Act of 2015, all provisions
H.R. 3081, TELEmedicine for MEDicare Act of 2015 (TELE-MED Act of 2015), all provisions
H.R. 2568, Fair Medical Audits Act of 2015, all provisions
H.R. 3309, Further Flexibility in HIT Reporting and Advancing Interoperability Act (Flex-IT 2 Act), all provisions
H.R. 270, Flexibility in Health IT Reporting (Flex-IT) Act of 2015, all provisions
H.R. 3100, Medical Practice Freedom Act of 2015, all provisions
H.R. 6, 21st Century Cures Act, all provisions
H.R. 2502, Comprehensive Care Payment Innovation Act of 2015, all provisions
H.R. 592, Pharmacy and Medically Underserved Areas Enhancement Act, all provisions
H.R. 3220, Medicare Common Access Card Act of 2015, all provisions
H.R. 1117, Creating Access to Residency Education Act of 2015, all provisions
S. 1148, Resident Physician Shortage Reduction Act of 2015, all provisions
H.R. 2, Medicare Access and CHIP Reauthorization Act of 2015, all provisions
H.R. 1470, SGR Repeal and Medicare Provider Payment Modernization Act of 2015, provisions relating to physician payment and delivery reform
S. 810, SGR Repeal and Medicare Provider Payment Modernization Act of 2015, provisions relating to physician payment and delivery reform
H.R. 1295, Trade Preferences Extension Act of 2015, provisions relating to Medicare sequester
H.R. 2146, Defending Public Safety Employees' Retirement Act, provisions relating to Medicare sequester
S. 1020, Diagnostic Imaging Services Access Protection Act of 2015, all provisions
Audit & Appeal Fairness
Medicare program: Medicare Advantage market transparency/beneficiary and provider protections
Medicare program: Protecting Access to Medicare Act (PAMA) implementation
Medicare program; Merit-based incentive models
Medicare program: Alternative payment models
Medicare program: Independent Payment Advisory Board Repeal (IPAB)
Medicare program: Medicare Physician Fee Schedule
Medicare program: Meaningful Use, Certification, Interoperability Roadmap
Medicare program: In-office Ancillary Services Exception
Medicare program: Graduate Medical Education
Medicare program: Electronic Health Records (EHR)/Meaningful Use (MU)
Medicare program: Merit-based Incentive Payment System (MIPS)
Medicare program: Two-Midnights Rule/Policy
Medicare program: Alternative Payment Models
Medicare program: Diabetes
Medicare program: Sunshine Act/CME, reprints and medical textbooks
Medicare program: Prescription Drug Diversion
Medicare program: Medicare physician data
Medicare program: Comprehensive Care for Joint Replacement (CCJR)
Medicare program: Misvalued Codes
Medicare program: Part B Drugs
Medicare program: Chronic Care
Medicare program: Sequestration
Medicare program: Recovery Audit Contractors (RACs)
Medicare program: Provider payments
Medicare program: Local Coverage Decisions
Medicare program: Enterprise Identity Management (EIDM) implementation
Medicare program: Regulatory burdens
Medicare program: Codes for drug abuse testing
Medicare program: Physician Quality Reporting Program/Value-based Modifier/Physician Compare
Medicare program: Diagnostic Coding
Medicare and Medicaid programs: Nomination of Andrew Slavitt to be CMS Administrator
Medicare and Medicaid programs: ICD-10
Medicare and Medicaid programs: Laboratory Developed Tests oversight and regulation
Medicare and Medicaid programs: Medicare Access and CHIP Reauthorization Act (MACRA) implementation
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS), Centers For Medicare and Medicaid Services (CMS), Office of Management & Budget (OMB), White House Office, U.S. SENATE, Government Accountability Office (GAO)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Lindsey |
Brill |
|
|
|
Aiken |
Hackett |
|
|
|
Dana |
Lichtenberg |
|
|
|
Jason |
Marino |
|
|
|
Thomas |
Roberge |
|
|
|
Andrew |
Wankum |
|
|
|
Margaret |
Garikes |
|
|
|
Shannon |
Curtis |
|
|
|
Sandy |
Marks |
|
|
|
Matthew |
Reid |
|
|
|
Koryn |
Rubin |
|
|
|
Mari |
Savickis |
|
|
|
Jason |
Scull |
|
|
|
George |
Cox |
III |
|
|
Eileen |
Carlson |
|
|
|
Debra |
Cohn |
|
|
|
Charles |
Kels |
|
|
|
Kristen |
O'Brien |
|
|
|
Sylvia |
Trujillo |
|
|
|
George |
Cox |
III |
|
|
Charles |
Kels |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TOR
16. Specific lobbying issues
H.R. 865, Good Samaritan Health Professionals Act of 2015, all provisions
H.R. 2603, Saving Lives, Saving Cost Act, all provisions
Medical Liability Reform
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Aiken |
Hackett |
|
|
|
Andrew |
Wankum |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code VET
16. Specific lobbying issues
H.R. 1688, To amend the Veterans Access, Choice, and Accountability Act of 2014 to designate 20 graduate medical education residency positions specifically for the study of optometry, all provisions
Veterans Affairs
Veterans Choice
Nursing Handbook
Joining Forces
Wellness Activities
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, Veterans Affairs - Dept of (VA)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Aiken |
Hackett |
|
|
|
Andrew |
Wankum |
|
|
|
Margaret |
Garikes |
|
|
|
George |
Cox |
III |
|
|
Kristen |
O'Brien |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
FY 2016 L-HHS Appropriations legislation, provisions relating to funding for the Center for Medicare and Medicaid Innovation (CMMI) and the Agency for Health Care Research and Quality (AHRQ)
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Jason |
Marino |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
| Address |
|
||||||
| City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
| City | Chicago |
State | IL |
Zip Code | 60611-5885 |
Country | USA |
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
| 1 |
|
3 |
|
||||||
| 2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
TOB |
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
| Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
||||||||||||||
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
| 1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
| Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% | |||||||||||||
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
| 1 | 3 | 5 |
| 2 | 4 | 6 |